DK0542364T3 - Anordning til reguleret frigivelse - Google Patents

Anordning til reguleret frigivelse

Info

Publication number
DK0542364T3
DK0542364T3 DK92203447.5T DK92203447T DK0542364T3 DK 0542364 T3 DK0542364 T3 DK 0542364T3 DK 92203447 T DK92203447 T DK 92203447T DK 0542364 T3 DK0542364 T3 DK 0542364T3
Authority
DK
Denmark
Prior art keywords
active substance
core
aperture
exposed
release
Prior art date
Application number
DK92203447.5T
Other languages
English (en)
Inventor
Sham Kumar Chopra
David Lee
Thomas Patrick Molloy
Avinash Kumar Nangia
Original Assignee
Glaxo Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919124106A external-priority patent/GB9124106D0/en
Priority claimed from GB919124108A external-priority patent/GB9124108D0/en
Priority claimed from GB929205463A external-priority patent/GB9205463D0/en
Application filed by Glaxo Canada filed Critical Glaxo Canada
Application granted granted Critical
Publication of DK0542364T3 publication Critical patent/DK0542364T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK92203447.5T 1991-11-13 1992-11-10 Anordning til reguleret frigivelse DK0542364T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919124106A GB9124106D0 (en) 1991-11-13 1991-11-13 Device
GB919124108A GB9124108D0 (en) 1991-11-13 1991-11-13 Device
GB929205463A GB9205463D0 (en) 1992-03-12 1992-03-12 Device

Publications (1)

Publication Number Publication Date
DK0542364T3 true DK0542364T3 (da) 1996-03-11

Family

ID=27265924

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92203447.5T DK0542364T3 (da) 1991-11-13 1992-11-10 Anordning til reguleret frigivelse

Country Status (15)

Country Link
US (1) US5342627A (da)
EP (1) EP0542364B1 (da)
JP (2) JP3768247B2 (da)
AT (1) ATE133331T1 (da)
AU (1) AU658942B2 (da)
CA (1) CA2082740C (da)
CZ (1) CZ337392A3 (da)
DE (1) DE69207863T2 (da)
DK (1) DK0542364T3 (da)
ES (1) ES2083074T3 (da)
GR (1) GR3019431T3 (da)
IL (1) IL103723A0 (da)
NO (1) NO924372L (da)
NZ (1) NZ245100A (da)
TW (1) TW262387B (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5398850A (en) 1993-08-06 1995-03-21 River Medical, Inc. Gas delivery apparatus for infusion
DE4341442C2 (de) * 1993-12-04 1998-11-05 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung
DE4431653C2 (de) * 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
US5700245A (en) 1995-07-13 1997-12-23 Winfield Medical Apparatus for the generation of gas pressure for controlled fluid delivery
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
US6110500A (en) * 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
EP1095650A1 (en) * 1999-10-29 2001-05-02 Universiteit Leiden Double phase time-controlled release system
US6569152B2 (en) 2000-03-21 2003-05-27 Farrington Pharmaceuticals, Llc Sustained release delivery systems for solutes
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
SK288222B6 (sk) * 2000-12-14 2014-09-04 Ortho-Mcneil Pharmaceutical, Inc. Steroidné hormonálne prípravky a spôsoby ich prípravy
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
CN1703197A (zh) * 2001-11-14 2005-11-30 阿尔扎有限公司 可注射的长效组合物和其使用
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
MXPA04004665A (es) 2001-11-14 2004-09-10 Alza Corp Composiciones de deposito inyectable y uso de los mismos.
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US7125563B2 (en) * 2002-04-12 2006-10-24 Dava Pharmaceuticals, Inc. Sustained release pharmaceutical preparations and methods for producing the same
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
BRPI0313148B8 (pt) * 2002-07-29 2021-05-25 Glaxo Group Ltd formulações sólidas matriciais de lamotrigina contendo revestimento externo e perfuração em tal revestimento
US8637512B2 (en) * 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
NZ537955A (en) * 2002-07-31 2007-10-26 Alza Corp Injectable depot compositions and uses thereof
CN101057824A (zh) * 2002-07-31 2007-10-24 阿尔萨公司 可注射的多模式聚合物储库组合物以及其用途
US20040068000A1 (en) * 2002-10-02 2004-04-08 Mintong Guo Compression coated tablets
GB0400452D0 (en) * 2004-01-09 2004-02-11 Norton Healthcare Ltd A pharmaceutical composition
US20050163847A1 (en) * 2004-01-21 2005-07-28 Andrx Pharmaceuticals, Llc Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug
GB0403628D0 (en) * 2004-02-18 2004-03-24 Arrow Group Ltd Compression-coated tablets and the manufacture thereof
PT1781264E (pt) 2004-08-04 2013-10-16 Evonik Corp Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma
GB0423964D0 (en) * 2004-10-28 2004-12-01 Jagotec Ag Dosage form
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
EP1970055B1 (en) * 2005-12-29 2010-11-24 Osmotica Kereskedelmi És Szolgáltató Kft Multi-layered tablet with triple release combination
US8691272B2 (en) * 2005-12-30 2014-04-08 Intelgenx Corp. Multilayer tablet
DE102007026037A1 (de) 2007-06-04 2008-12-11 Lts Lohmann Therapie-Systeme Ag Gastroretentives System mit Alginat-Körper
JP5502751B2 (ja) 2007-12-20 2014-05-28 エボニック コーポレイション 低残留溶媒濃度を有する微粒子を調製するためのプロセス
CA2734095A1 (en) * 2008-08-14 2010-02-18 Bioneer A/S Coated tablets with a remaining degradation surface over the time
WO2010096820A1 (en) * 2009-02-23 2010-08-26 Eurand, Inc. Controlled release compositions comprising anti-cholinergic drugs
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110136815A1 (en) * 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
CA2792523C (en) * 2010-03-09 2018-01-09 Alkermes Pharma Ireland Limited Alcohol resistant enteric pharmaceutical compositions
US9233076B2 (en) 2010-12-13 2016-01-12 Purdue Pharma L.P. Controlled release dosage forms
US20160303242A1 (en) 2013-12-09 2016-10-20 Durect Corporation Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
EP3132246A4 (en) 2014-04-14 2017-12-13 Abbott Molecular Inc. Medium used for blood sample collection and transport
CA2902911C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US480076A (en) * 1892-08-02 Thomas p
US3113076A (en) * 1956-07-03 1963-12-03 Henry R Jacobs Medicinal tablets
GB1022171A (en) * 1961-06-15 1966-03-09 Wellcome Found Prolonged release oral pharmaceutical tablets and their manufacture
US3851648A (en) * 1973-10-11 1974-12-03 Mead Johnson & Co Zero-order release device
US4816262A (en) * 1986-08-28 1989-03-28 Universite De Montreal Controlled release tablet
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance

Also Published As

Publication number Publication date
AU2827292A (en) 1993-05-20
ATE133331T1 (de) 1996-02-15
NO924372D0 (no) 1992-11-12
TW262387B (da) 1995-11-11
JP3768247B2 (ja) 2006-04-19
CA2082740A1 (en) 1993-05-14
US5342627A (en) 1994-08-30
NO924372L (no) 1993-05-14
DE69207863T2 (de) 1996-06-05
JP4166716B2 (ja) 2008-10-15
JPH05262640A (ja) 1993-10-12
NZ245100A (en) 1995-06-27
EP0542364A1 (en) 1993-05-19
JP2004189754A (ja) 2004-07-08
DE69207863D1 (de) 1996-03-07
IL103723A0 (en) 1993-04-04
AU658942B2 (en) 1995-05-04
CZ337392A3 (en) 1993-10-13
ES2083074T3 (es) 1996-04-01
CA2082740C (en) 2003-10-14
EP0542364B1 (en) 1996-01-24
GR3019431T3 (en) 1996-06-30

Similar Documents

Publication Publication Date Title
DK0542364T3 (da) Anordning til reguleret frigivelse
NO962287D0 (no) Innretning for regulert frigivelse av virkestoffer
ES2126553T3 (es) Dispositivo dosificador y su uso.
GB2230441B (en) Controlled release device
DK618088A (da) Farmaceutisk doseringsform til kontrolleret afgivelse af aktivt stof
DK0436370T3 (da) Farmaceutisk præparat til kontrolleret afgivelse og fremgangsmåde til fremstilling deraf
DE69010411D1 (de) Szenenabhängige kompensation inhomogen verteilter detektorempfindlichkeit einer bilddetektormatrix.
DE68905850T2 (de) Zusammensetzung zur Beschichtung der Aussenoberfläche von Sportbällen und so erhaltene Bälle.
ATE439770T1 (de) Riechstoffzusammensetzung
CA2134885A1 (en) Reduced odor fragrance sampler
NO894467D0 (no) Reservoar for styrt frigjoering av aktive substanser, anordning som inneholder den, fremgangsmaate for aa fremstille den, og bruk av anordningen.
MY106930A (en) Controlled release device
ES520397A0 (es) Procedimiento para la obtencion de pesticidas a base de microemulsiones en agua.
ATE212543T1 (de) Pharmazeutische zusammensetzung aus stabilisierten lipophilen matrizen mit kontrollierter wirkstofffreisetzung
JPS5416444A (en) Optically active alpha-cyano-3-phenoxybenzyl 2-(4-chlorophenyl)-isovalerate and its preparation
RU92004402A (ru) Устройство для регулируемого выделения активного вещества и способ его изготовления
EP0305194A3 (en) Veterinary composition